Pharmaceuticals Products

Generic:

Ciprofloxacin

Therapeutic Segment:

Antibiotic

Indications:

Treatment of patients with mild to moderate infections caused by susceptible strains of the designated micro-organisms in the specific conditions listed below:

• Broncho-pulmonary infections.
• ENT infections.
• Infections of mouth, teeth and jaws.
• Uncomplicated acute cystitis.
• Complicated urinary tract infections and acute pyelonephritis.
• Bacterial prostatitis.
• Gonococcal urethritis and cervicitis.
• Gastrointestinal infections.
• Infections of the bones and joints.
• Wound and soft tissue infections.
• Peritonitis.

Available as:
Tablets:

5mg
10mg

Injections:

200mg /100ml

Generic:

Ceftriaxone sodium

Therapeutic Segment:

Antibiotic

Indications:

Treatment of infections caused by susceptible strains of the designated micro-organisms in the specific conditions listed below:

• Lower respiratory tract infections (acute bacterial bronchitis, community-acquired pneumonia, influenza and XDR typhoid fever).
• Sepsis.
• Meningitis.
• Uncomplicated acute cystitis.
• Disseminated lyme borreliosis (early and late stages of the disease).
• Abdominal infections (peritonitis, infections of the biliary and gastrointestinal tract).
• Infections of the bones, joints, soft tissues and skin.
• Infections in patients with impaired defense mechanism.
• Renal and urinary tract infections.
• Respiratory tract infections, particularly pneumonia, ear, nose and throat infections.
• Genital infections including gonorrhea.
• Pre-operative prophylaxis of infections.

Available as:

Injections:

250mg
500mg
1g
2g

Generic:

Cefepime

Therapeutic Segment:

Antibiotic

Indications:

Treatment of infections caused by susceptible strains of the designated micro-organisms in the specific conditions listed below:

• Lower respiratory tract infections including pneumonia and bronchitis.
• Urinary tract infections including pyelonephritis.
• Skin and skin structure infections.
• Intra-abdominal infections including peritonitis and biliary tract infections.
• Gynecologic infections.
• Septicemia.
• Empiric treatment in febrile neutropenia.
• Surgical prophylaxis in intra-abdominal surgeries.

Available as:

Injections:

500mg
1g

Generic:

Cefotaxime

Therapeutic Segment:

Antibiotic

Indications:

Treatment of infections caused by susceptible strains of the designated micro-organisms in the specific conditions listed below:

• Tonsillitis, pneumonia, bronchitis, bronchial extensions, secondary infections of chronic respiratory tract diseases, abscess of lung and emphysema.
• Pyelitis, urinary tract infections, gonorrhea, prostatitis, adnexitis, endometritis, infections around uterus and bartholinitis.
• Meningitis, septicemia and bacterial endocarditis.
• Osteomyelitis and septic arthritis.
• Peritonitis, cholecystitis and cholangitis.
• Prophylaxis for patients with impaired immune function.

Available as:

Injections:

250
500mg
1g

Generic:

Moxifloxacin

Therapeutic Segment:

Antibiotic

Indications:

• Acute bacterial sinusitis.
• Acute exacerbation of chronic obstructive pulmonary disease including bronchitis.
• Community-acquired pneumonia.
• Uncomplicated and complicated skin and skin structure infections.

Available as:

Tablets:

400mg

Generic:

Ofloxacin

Therapeutic Segment:

Antibiotic

Indications:

Treatment of patients with mild to moderate infections caused by susceptible strains of the designated micro-organisms in the specific conditions listed below:

• Acute bacterial exacerbations of chronic bronchitis.
• Community acquired Pneumonia.
• Uncomplicated skin and skin structure infections.
• Acute, uncomplicated urethral and cervical gonorrhea.
• Nongonococcal urethritis and cervicitis.
• Pelvic inflammatory disease.
• Uncomplicated cystitis.
• Complicated urinary tract infections and prostatitis.

Available as:

Tablets:

200mg

Generic:

Ceftriaxone

Therapeutic Segment:

Antibiotic

Indications:

Treatment of patients with mild to moderate infections caused by susceptible strains of the designated micro-organisms in the specific conditions listed below:

• Lower respiratory tract infections (acute bacterial bronchitis, community-acquired pneumonia, influenza and XDR typhoid fever).
• Sepsis.
• Meningitis.
• Disseminated lyme borreliosis (early and late stages of the disease).
• Abdominal infections (peritonitis, infections of the biliary and gastrointestinal tract).
• Infections of the bones, joints, soft tissues and skin.
• Infections in patients with impaired defense mechanism.
• Renal and urinary tract infections.
• Respiratory tract infections, particularly pneumonia, ear, nose and throat infections.
• Genital infections including gonorrhea.
• Pre-operative prophylaxis of infections

Available as:

Injections:

250mg
1g

Generic:

Levofloxacin

Therapeutic Segment:

Antibiotic

Indications:

Treatment of patients with mild to moderate infections caused by susceptible strains of the designated micro-organisms in the specific conditions listed below:

• Acute maxillary sinusitis.
• Acute exacerbation of chronic obstructive pulmonary disease including bronchitis.
• Community acquired pneumonia.
• Typhoid and paratyphoid fever.
• Complicated and uncomplicated skin and skin structure infections.
• Complicated and uncomplicated urinary tract infections.
• Acute pyelonephritis.

Available as:

Tablets:

250mg
500mg
750mg

Generic:

Meropenem

Therapeutic Segment:

Antibiotic

Indications:

• Severe pneumonia.
• Broncho-pulmonary infections in cystic fibrosis.
• Complicated urinary tract infections.
• Complicated intra-abdominal infections.
• Intra and postpartum infections.
• Complicated skin ad soft tissue infections.
• Septicemia.
• Febrile neutropenia.
• Acute bacterial meningitis.

Available as:

Injections:

500mg
1g

Generic:

Cefixime

Therapeutic Segment:

Antibiotic

Indications:

Treatment of patients with mild to moderate infections caused by susceptible strains of the designated micro-organisms in the specific conditions listed below:

• Uncomplicated urinary tract infections.
• Otitis media.
• Pharyngitis and tonsillitis.
• Acute bronchitis and acute exacerbation of chronic bronchitis.
• Uncomplicated gonorrhea (cervical/urethral).

Available as:

Capsules:

200mg 400mg

Suspensions:

100mg /5ml 200mg /5ml

Generic:

Cefoperazone + Sulbactam

Therapeutic Segment:

Antibiotic

Indications:

Treatment of infections caused by susceptible strains of the designated micro-organisms in the specific conditions listed below:

• Upper and lower respiratory tract infections.
• Upper and lower urinary tract infections.
• Peritonitis, cholecystitis, cholangitis and other intra-abdominal infections.
• Septicemia.
• Meningitis.
• Skin and soft tissue infections.
• Bone and joint infections.
• Pelvic inflammatory disease, endometritis, gonorrhea and other infections of genital tract.

Available as:

Injections:

1g
2g

Generic:

Azithromycin

Therapeutic Segment:

Antibiotic

Indications:

Treatment of patients with mild to moderate infections caused by susceptible strains of the designated micro-organisms in the specific conditions listed below:

• Lower respiratory tract infections (acute bacterial bronchitis, community-acquired pneumonia, influenza and XDR typhoid fever).
• Upper respiratory tract infections (acute sinusitis, acute streptococcal pharyngitis/tonsillitis and acute otitis media in children).
• Uncomplicated skin and skin structure infections and acne.
• Sexually transmitted diseases (uncomplicated urethritis and cervicitis).
• Pelvic inflammatory diseases in patients who require initial intravenous therapy.
• Chlamydial infections.

Available as:

Tablets:

250mg
500mg

Supension:

200mg / 5ml

Generic:

Ebastine

Therapeutic Segment:

Antiallergic

Indications:

• Seasonal allergic rhinitis.
• Perennial allergic rhinitis.
• Chronic idiopathic urticaria.

Available as:

Tablets:

10mg
20mg

Generic:

Montelukast

Therapeutic Segment:

Antiasthmatic

Indications:

• Prophylaxis and chronic treatment of asthma, allergic rhinitis and exercise-induced bronchoconstriction.

Available as:

Tablets:

5mg
10mg

Sachets:

4mg

Generic:

Loratadine

Therapeutic Segment:

Antiallergic

Indications:

• Allergic rhinitis.
• Chronic urticaria and other allergic dermatological disorders.

Available as:

Tablets:

10mg

Generic:

Jardin-D^®

Generic:

Desloratadine

Therapeutic Segment:

Antiallergic

Indications:

• Seasonal allergic rhinitis.
• Perennial allergic rhinitis.
• Chronic idiopathic urticaria.

Available as:

Tablets:

5mg

Syrup:

0.5mg/ml

Close

Therapeutic Segment:

Antiallergic

Indications:

• Allergic rhinitis.
• Chronic urticaria and other allergic dermatological disorders.

Available as:

Tablets:

10mg

Generic:

Empagliflozin

Therapeutic Segment:

antidiabetic

Indications:

• As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
• When diet and exercise alone do not provide adequate glycemic control in patients for whom the use of metformin is considered inappropriate due to intolerance.
• In combination with other glucose-lowering medicinal products including insulin, when these, together with diet and exercise, do not provide adequate glycemic control.

Available as:

Tablets:

10mg
25mg

Generic:

Empagliflozin + Metformin

Therapeutic Segment:

Antidiabetic

Indications:

• For the treatment of adults with type 2 diabetes mellitus as an adjunct to diet and exercise.
• In patients insufficiently controlled on their maximally tolerated dose of metformin alone.
• In combination with other medicinal products for the treatment of diabetes, in patients insufficiently controlled with metformin and these medicinal products.
• In patients already being treated with the combination of empagliflozin and metformin as separate tablets.

Available as:

Tablets:

12.5mg + 500mg
12.5mg + 850mg
12.5mg + 1000mg

Generic:

Vildagliptin

Therapeutic Segment:

Antidiabetic

Indications:

• The treatment of type 2 diabetes mellitus in adults as monotherapy in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindication or intolerance.
• As dual oral therapy in combination with metformin, in patients with insufficient glycemic control despite a maximally tolerated dose of monotherapy with metformin.
• As triple oral therapy in combination with sulfonylureas and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycemic control.
• Also indicated for use in combination with insulin (with or without metformin) when diet and exercise plus a stable dose of insulin do not provide adequate glycemic control.

Available as:

Tablets:

50mg

Generic:

Vildagliptin + Metformin

Therapeutic Segment:

Antidiabetic

Indications:

• For the treatment of adults with type 2 diabetes mellitus as an adjunct to diet and exercise.
• In patients whose diabetes is not adequately controlled on metformin or vildagliptin as separate tablets.

Available as:

Tablets:

50mg + 500mg
50mg + 850mg
50mg + 1000mg

Generic:

Glimepiride

Therapeutic Segment:

Antidiabetic

Indications:

• As an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes whose diabetes is not adequately controlled by diet and exercise alone.

Available as:

Tablets:

1mg
2mg
3mg
4mg

Generic:

Glimepiride + Metformin

Therapeutic Segment:

Antidiabetic

Indications:

• Pre-operative prophylaxis of infections

Available as:

Tablets:

2mg + 500mg

Generic:

Iron Sucrose

Therapeutic Segment:

Hematinic

Indications:

• For the treatment of iron deficiency anemia in patients with chronic kidney disease (CKD).
• Iron deficiency because of other reasons (before and after surgery, final stages of pregnancy, intolerance, non-responsiveness or non-compliance to oral iron therapy, malabsorption etc).

Available as:

Injections:

100mg/5ml

Generic:

Iron (III) Hydroxide Polymaltose Complex

Therapeutic Segment:

Hematinic

Indications:

For the prevention and treatment of iron deficiency anemia:

• During pregnancy and lactation.
• In children, adolescents, women of childbearing age and adults.

Available as:

Chewable Tablets:

100mg

Syrup:

50mg/5ml

Generic:

Iron (III) Hydroxide Polymaltose Complex + Folic Acid

Therapeutic Segment:

Antianemic

Indications:

• For the treatment of latent and manifest iron deficiency anemia.
• To prevent iron and folic acid deficiency before, during and after pregnancy (during lactation).

Available as:

Chewable Tablets:

100mg + 0.35mg

Generic:

Letrozole

Therapeutic Segment:

Aromatase Inhibitor

Indications:

• For the treatment of all stages of hormone receptor-positive breast cancer in postmenopausal women.

Available as:

Tablets:

2.5mg

Generic:

Artemether + Lumefantrine

Therapeutic Segment:

Antimalarial

Indications:

• Treatment of adults and children with acute, uncomplicated infections due to plasmodium falciparum, including malarial infections acquired in areas where the parasites may be resistant to other anti-malarials.

Available as:

Tablets:

20mg + 120mg
40mg + 240mg
80mg + 480mg

Generic:

Artemether

Therapeutic Segment:

Antimalarial

Indications:

• Treatment of all kinds of malaria, including chloroquine-resistant malaria and first aid for fatal malaria.

Available as:

Injections:

80mg

Generic:

Fluconazole

Therapeutic Segment:

Antifungal

Indications:

• Acute or recurrent vaginal candidiasis.
• Mucosal candidiasis e.g oropharyngeal, oesophageal, bronchopulmonary, mucocutaneous & denture sore mouth.
• Athlete’s foot (Tinea pedis), ringworm (Tinea corporis), Tinea cruris, Tinea versicolor & dermal candida infection.
• Cryptococcosis, Cryptococcal meningitis and infections of other sites (pulmonary & cutaneous).
• Prevention of fungal infection in immunocompromised patients.

Available as:

Capsule:

150mg

Generic:

Rosuvastatin

Therapeutic Segment:

Antihyperlipidemic

Indications:

• Management of hypercholesterolemia, mixed dyslipidemia, hypertriglyceridemia (HTG) and homozygous familial hypercholesterolemia.

Available as:

Tablets:

5mg
10mg
20mg

Generic:

Coenzyme Q10

Therapeutic Segment:

Cardiovascular health

Indications:

• Management of chronic heart failure, hypertension, male infertility, statin induced myalgia and anti-aging.

Available as:

Softgel Capsules:

100mg

Generic:

Atorvastatin

Therapeutic Segment:

Antihyperlipidemic

Indications:

• Management of hypercholesterolemia, mixed dyslipidemia, hypertriglyceridemia (HTG) and homozygous familial hypercholesterolemia.

Available as:

Tablets:

10mg
20mg
40mg

Generic:

Losartan potassium

Therapeutic Segment:

Antihypertensive

Indications:

• Hypertension.
• Ventricular hypertrophy.
• Ventricular hypertrophy.
• Diabetic neuropathy with an elevated serum creatinine and proteinuria in type 2 diabetic patients.

Available as:

Tablets:

25mg
50mg

Generic:

Losartan potassium + Hydrochlorothiazide

Therapeutic Segment:

Antihypertensive

Indications:

• Hypertension.
• Ventricular hypertrophy.

Available as:

Tablets:

50mg + 12.5mg

Generic:

Amlodipine

Therapeutic Segment:

Antihypertensive

Indications:

• Hypertension.
• Prophylaxis of chronic stable angina pectoris.
• Confirmed or suspected vasospastic angina.

Available as:

Tablets:

5mg
10mg

Generic:

Cholecalciferol

Therapeutic Segment:

Vitamin and Vitamin Analogue

Indications:

• For the prevention and treatment of vitamin D deficiency.

Available as:

Softgel Capsules:

200,000 IU

Generic:

Cholecalciferol

Therapeutic Segment:

Vitamin and Vitamin Analogue

Indications:

• For the prevention and treatment of vitamin D deficiency.
• Recommended in rickets due to vitamin D resistance.

Available as:

Injections:

5mg (200,000 IU) /ml

Generic:

Omeprazole

Therapeutic Segment:

Antiulcerant

Indications:

• Gastroesophageal reflux disease (GERD).
• Gastric and duodenal ulcers.
• Treatment and prophylaxis of NSAID-associated ulceration.
• Eradication of H.pylori infection associated with peptic ulcer disease.
• Zollinger-Ellison syndrome.
• Dyspepsia.
• Prophylaxis of acid aspiration.

Available as:

Capsules:

20mg
40mg

Infusion:

40mg

Generic:

Omeprazole + Sodium Bicarbonate

Therapeutic Segment:

Antiulcerant

Indications:

• Treatment of gastroesophageal reflux disease (GERD), heartburn and other symptoms associated with GERD and treatment of erosive esophagitis (EE) which has been diagnosed by endoscopy.
• Short-term treatment of active duodenal ulcer.
• Treatment and prophylaxis of NSAID-associated ulceration.
• Short-term treatment of active benign gastric ulcer.
• Maintenance treatment of healing of erosive esophagitis (EE).
• Reduction treatment of risk of upper gastrointestinal bleeding in critically ill patients.

Available as:

Sachet:

40mg + 1680mg

Generic:

Esomeprazole

Therapeutic Segment:

Antiulcerant

Indications:

• Gastroesophageal reflux disease (GERD) & symptomatic GERD without esophagitis.
• Erosive esophagitis (EE), long-term management of patients with healed esophagitis to prevent relapse.
• H. pylori eradication to reduce the risk of duodenal ulcer.
• Short-term treatment of gastroesophageal reflux disease (GERD) with erosive esophagitis (EE) in adults and pediatric patients 1 month to 17 years of age, as an alternative to oral therapy when oral esomeprazole is not possible or appropriate.
• Risk reduction of re-bleeding of gastric or duodenal ulcers following therapeutic endoscopy for acute bleeding of gastric or duodenal ulcers in adults.

Available as:

Capsules:

20mg
40mg

Injections:

40mg

Generic:

Levosulpiride

Therapeutic Segment:

Gastroprokinetic

Indications:

• Gastroesophageal reflux disease (GERD).
• Irritable bowel syndrome.
• Dyspeptic syndrome due to delayed gastric emptying.
• Vertigo.
• Schizophrenia.

Available as:

Tablets:

25mg
50mg

Generic:

Itopride Hydrochloride

Therapeutic Segment:

Gastroprokinetic

Indications:

• Functional dyspepsia.
• Non-ulcer dyspepsia (chronic gastritis).ally ill patients.

Available as:

Tablets:

50mg

Generic:

Famotidine

Therapeutic Segment:

Antiulcerant

Indications:

• Duodenal ulcers.
• Prevention of recurrence of duodenal ulcers.
• Benign gastric ulcer.
• Gastroesophageal reflux.
• Hypersecretory conditions such as Zollinger-Ellison syndrome.

Available as:

Tablets:

20mg
40mg

Generic:

Domperidone

Therapeutic Segment:

Gastroprokinetic

Indications:

• Dyspeptic symptom complex that is often associated with delayed gastric emptying, gastroesophageal reflux and esophagitis.
• Prevention and treatment of nausea and vomiting.

Available as:

Tablets:

10mg

Generic:

Tamsulosin HCI

Therapeutic Segment:

Urology

Indications:

• The treatment of the signs and symptoms of benign prostatic hyperplasia (BPH).

Available as:

Capsules:

0.4mg

Generic:

Cranberry Extract

Therapeutic Segment:

Urinary tract health

Indications:

• It is effective in reducing the incidence of urinary tract infections (UTI).

Available as:

Sachet:

250mg

Generic:

Tramadol HCl + Paracetamol

Therapeutic Segment:

Analgesic

Indications:

• Management of moderate to severe painful conditions.

Available as:

Tablets:

37.5mg
325mg

Generic:

Piroxicam-β-cyclodextrin

Therapeutic Segment:

Analgesic

Indications:

• A variety of acute painful conditions requiring anti-inflammatory and analgesic activity, including rheumatoid arthritis, osteo-arthritis (arthrosis, degenerative joint disease), ankylosing spondylitis, musculoskeletal and joint disorders, gout, in soft-tissue disorders and in post-operative pain.

Available as:

Tablets:

20mg

Generic:

Diclofenac Sodium

Therapeutic Segment:

Analgesics

Indications:

• For the treatment of rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, low back pain, frozen shoulder, tendinitis, tenosynovitis, bursitis, strains, sprains & acute gout.
• To control the pain and inflammation in orthopedic, dental and minor surgeries.
• In children, for the treatment of juvenile chronic arthritis.

Available as:

Tablets:

50mg
100mg

Generic:

Tizanidine

Therapeutic Segment:

Muscle Relaxant

Indications:

• Treatment of painful muscle spasms.
• Treatment of spasticity due to neurological disorders.

Available as:

Tablets:

2mg
4mg